- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02624193
Health Improvement for Baltimore Youth
Improving Treatment Adherence in HIV-Positive Youth Through Mindfulness Training
Study Overview
Status
Intervention / Treatment
Detailed Description
Despite remarkable advances in HIV medication effectiveness, adherence to HIV treatment recommendations is alarmingly poor, resulting in preventable morbidity and mortality. It is estimated that 26-72% of HIV-infected adolescents are non-adherent to their HIV medications and 22-33% are non-adherent with scheduled health care visits. HIV treatment non-adherence puts individuals at markedly increased risk for illness related to HIV itself and a variety of opportunistic infections, as well as at increased risk of spreading HIV.
Preliminary data from the investigators' NCCAM-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved medication adherence, as well as enhanced self-regulatory processes (coping, psychological function, and cognitive function). This two-armed randomized, controlled trial will help the investigators to better understand the specific impact of MBSR on HIV medication and treatment adherence in HIV-infected youth, and the efficacy of MBSR in the amelioration of stress and improved self-regulation.
The aims of the study are as follows:
Primary Objective
Investigators hypothesize that MBSR vs. active control program (HT) participation will be associated with:
• (H1) Improved HIV medication adherence (self-report validated by HIV viral load) at 3 months, 6 months, and 12 months
Secondary Objectives
Investigators also hypothesize that MBSR vs. active control program (HT) participation will be associated with:
- (H2) Improved coping at 3, 6, and 12 months
- (H3) Improved psychological functioning at 3, 6, and 12 months
- (H4) Improved cognitive functioning at 3, 6, and 12 months
Investigators will also explore:
- associations (and potential mediation) among mindfulness, self-regulation, and HIV medication adherence and
- using qualitative methods, experience with MBSR, HIV treatment adherence, as well as reasons for non-participation in the study and non-attendance of program sessions to inform future implementation planning.
- gender differences in the effects of MBSR versus HT on emotion regulation and physiological responses to stressful stimuli.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical Center
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Harriet Lane Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 13-24 years of age
- English speaking
- Receiving care at the adolescent outpatient clinics at Johns Hopkins Children's Center (JHCC/University of Maryland Medical Center (UMMC)/Moore Clinic
- Positive for HIV and aware of his/ her status
- Prescribed anti-retroviral therapy (ART)
- Able to attend and participate in the 9 week program sessions
Exclusion Criteria:
- patient currently exhibits significant psychological, developmental, or behavioral issues as assessed by the site clinical staff
- participated in a previous MBSR program or studies
Exclusion Criteria for supplement study:
• patient is transgender
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MBSR Program
MBSR Program: The MBSR intervention is a nine-week program designed to cultivate mindfulness, a focused non-judgmental awareness of the present moment. It consists of eight 2-hour weekly sessions and one 3-hour retreat and the content includes three main components: 1) material related to mindfulness, meditation, yoga, and the mind-body connection; 2) experiential practice of mindful meditation (sitting, lying down, walking), gentle mindful yoga, and "body scan" during group meetings and encouragement of home practice; and 3) group discussion focused on problem-solving related to barriers to effective practice. HIV disease will not be discussed as a group topic, unless it is brought up by participants. |
Mindfulness-based stress reduction, as described previously.
Other Names:
|
|
Placebo Comparator: HT Program
Healthy Topics Program: The health education program "Healthy Topics" (HT) will serve as an attention control group. The HT program is focused on providing age-appropriate health information and education. There is minimal content overlap in the MBSR and HT programs regarding self-care and healthy eating; however, the style, structure, and content of the MBSR and HT programs are distinct. HT participants will receive no training in MBSR or meditation. Topics covered include physical activity, nutrition, managing weight, building health, personal care, understanding adolescence, tobacco, alcohol, and other drugs. HIV disease will not be discussed as a group topic, unless it is brought up by participants. |
Health education curriculum, as described previously
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Treatment Adherence
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on treatment adherence as measured by the Adolescent Medicine Trials Network (ATN) HIV Medication Adherence self-report measure, as well as CD4 and viral load counts pulled from the participant's medical record.
The measure and medical record data collection takes place at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NIH Emotion Measures Questionnaire
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Specific NIH emotion measures are: meaning & purpose, positive affect, anger, fear, perceived hostility, sadness.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Illness Cognition (IC) Scale
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on thoughts of illness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on issues in emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Mindful Acceptance and Awareness Scale (MAAS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Five Facet Mindfulness Questionnaire (FFMQ)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on multiple aspects of mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Differential Emotions Scale (DES) - selected items
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on frequency of emotions (specifically, self-hostility, shame, shyness, and guilt) measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
State-Trait Anger Expressivity Inventory (STAXI)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on anger expression measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Children's PTSD Symptom Severity Checklist (CPSS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on trauma symptoms measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Compassion Scale
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on self-compassion measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Perceived Stress Scale (PSS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on perceived stress measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Sex Risk Scale
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on risky sexual behavior measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Lesbian & Gay Identity Scale (LGIS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on self-acceptance of lesbian/gay/bisexual identity measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
General Health Assessment
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on general health measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Youth Quality of Life scale (YQOL)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on quality of life measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Brief COPE Questionnaire
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on coping measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Children's Response Style Questionnaire (CRSQ)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on coping responses measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Das-Naglieri Cognitive Assessment System (CAS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Emotion Stroop Task
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
Assessment of impact of MBSR versus HT on emotion-based cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berkeley Expressivity Questionnaire (BEQ)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on emotion expressivity (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Children's Emotion Management Scales (CEMS)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on management of anger, sadness, happiness, pride, and worry (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Differential Emotions Scale (DES)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on the frequency of emotions, specifically disgust, joy, sadness, surprise, contempt, interest, fear, and anger, (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Emotion Regulation Questionnaire (ERQ)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on emotion regulation (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Emotion Approach Coping Scale (EAC)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on emotion approach coping (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Flanker Inhibitory Control and Attention Test Age 12+ v2.0
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on stress response, and inhibitory control and attention (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
List Sorting Working Memory Test Age 7+ v2.0
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on stress response, and working memory (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Dimensional Change Card Sort Test Age 12+ v2.0
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on stress response, and cognitive flexibility, measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Picture Sequence Memory Test Age 8+ (Form A) v2.0
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on stress response, and episodic memory measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
|
Heart Rate Variability (HRV)
Time Frame: Baseline, and follow up at 3, 6, and 12 months
|
For those selected to be in the supplement study, assessment of impact of MBSR versus HT on stress response measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up.
|
Baseline, and follow up at 3, 6, and 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Erica Sibinga, MD, Johns Hopkins School of Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NA_00093335
- 1R01AT007888 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on MBSR Program
-
Cecile LengacherCompletedBreast CancerUnited States
-
Azienda Unita Sanitaria Locale di PiacenzaUniversity of Siena, ItalyCompleted
-
Mersin UniversityNot yet recruiting
-
Halic UniversityCompletedMultiple Sclerosis | Mindfulness | Upper Motor Neuron LesionTurkey
-
Washington University School of MedicineCompleted
-
Irmandade da Misericórdia de Albergaria-a-VelhaCompletedAnxiety Depression (Mild or Not Persistent)
-
University Hospital, ToursCompleted
-
University of South FloridaCompletedBreast CancerUnited States
-
Muş Alparslan UniversityAtaturk UniversityActive, not recruitingSleep Quality | Stress Reduction | Adolescent Behaviour Disorder | Digital AddictionTurkey (Türkiye)
-
Nova Southeastern UniversityCompleted